论文部分内容阅读
孟山都公司在其对美国加州环保局环境健康损害评估办公室的诉讼中败诉,导致其旗舰产品草甘膦被列入加州致癌物质清单。这一事件引起我国相关企业及公众的广泛关注。被告将草甘膦列入致癌物质清单/要求加贴警示标签的做法,虽然经受住了加州弗雷斯诺县高级法院的违宪审查,但涉嫌违反美国政府在WTO《SPS协议》项下所承担的义务,同时还构成我国贸易壁垒调查制度意义上的贸易壁垒。
Monsanto failed in its lawsuit against the California Environmental Protection Agency’s Office of Environmental Health Damage Assessment, leading its flagship product, glyphosate, to be included in the California carcinogen inventory. This incident has aroused widespread concern in China’s related enterprises and the public. The defendant’s inclusion of glyphosate in the list of carcinogens / labeling of warning signs, despite being subjected to unconstitutional review by the Fresno County High Court in California, is suspected of violating the U.S. government’s commitment under the WTO SPS Agreement Obligations, while also constituting the trade barriers in the context of China’s trade barrier investigation system.